| HGNC Family | EF-hand domain containing |
| Name | sorcin |
| Description | This gene encodes a calcium-binding protein with multiple E-F hand domains that relocates from the cytoplasm to the sarcoplasmic reticulum in response to elevated calcium levels. In addition to regulating intracellular calcium homeostasis it also modulates excitation-contraction coupling in the heart. Alternative splicing results in multiple transcript variants encoding distinct proteins. Multiple pseudogenes exist for this gene. [provided by RefSeq, Mar 2012] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSorcin (SRI) is emerging as a multifunctional calcium‐binding protein whose aberrant expression plays a central role in the development and progression of cancer. In numerous malignancies—including acute leukemias, colorectal, gastric, nasopharyngeal, breast, ovarian, and hepatocellular carcinomas—sorcin is markedly overexpressed and has been linked to the onset of multidrug resistance. By interacting with proteins such as the mitochondrial chaperone TRAP1 and regulators of Ca²⁺ homeostasis, sorcin modulates anti‐apoptotic pathways, stimulates drug efflux (via up‐regulation of P‐glycoprotein and related transporters), and supports the epithelial‐to‐mesenchymal transition and cancer stem cell characteristics that underlie tumor aggressiveness and metastasis. Moreover, sorcin expression correlates with poor clinical outcomes and advanced tumor stage, suggesting its potential as both a prognostic biomarker and a therapeutic target for overcoming chemoresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "19"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its oncogenic implications, sorcin is a key modulator of intracellular calcium dynamics in several non‐malignant settings. In the heart, studies in transgenic and adenovirus‐transfected models have demonstrated that sorcin regulates excitation–contraction coupling by modulating ryanodine receptor activity and L‐type calcium currents, thereby contributing to contractile function. In pancreatic β‐cells, sorcin sequesters transcription factors (such as ChREBP) in the cytosol in a Ca²⁺‐dependent manner, thus influencing glucose‐mediated gene expression. Its role in preserving endoplasmic reticulum Ca²⁺ levels and preventing ER stress is also evident in neurodegenerative conditions, where sorcin’s interaction with SERCA, ryanodine receptors, and other ER components appears to counteract the toxic effects of amyloid‐β and tau. Furthermore, sorcin contributes to the regulation of calcium sparks in vascular smooth muscle, underpinning its broader role as a calcium sensor and effector."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "20", "end_ref": "29"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in calcium regulation and chemoresistance, sorcin is intricately involved in the fine‐tuning of intracellular signaling and cell cycle progression. It interacts with a range of regulatory proteins—from kinases such as PLK1 and Aurora family members to components implicated in the cAMP response element–binding (CREB) pathway—to modulate apoptosis, mitosis, and cytokinesis. These functions, which extend to controlling the expression of drug transporters and influencing the balance between pro‐ and anti‐apoptotic factors, reinforce sorcin’s status as a multifaceted intracellular mediator and a promising target for therapeutic intervention in both cancer and other diseases where calcium dysregulation is pathogenic."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "30", "end_ref": "37"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Guangyao Li, Yaohong Tan, Chunzheng Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and clinical implication of soluble resistance-associated calcium-binding protein gene and multi-drug resistance gene in leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Zhong Liu Za Zhi (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12408767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12408767"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Guangyao Li, Yaohong Tan, Chunzheng Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and clinical implications of the soluble drug resistance-related calcium-binding protein (sorcin) gene in leukemia patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Xue Ye Xue Za Zhi (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12411058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12411058"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jing Qi, Ning Liu, Yuan Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2006.08.042"}], "href": "https://doi.org/10.1016/j.bbrc.2006.08.042"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16934756"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16934756"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Qing-Chun He, Gui-Ying Zhang, Wei-Jun Cao "}, {"type": "b", "children": [{"type": "t", "text": "[Correlation of sorcin overexpression to multidrug resistance of human gastric cancer cell line SGC7901]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ai Zheng (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18423116"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18423116"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Langmei Deng, Tao Su, Aimin Leng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-009-9342-5"}], "href": "https://doi.org/10.1007/s12032-009-9342-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19885748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19885748"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yiqing Qu, Yie Yang, Baoyi Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-009-9379-5"}], "href": "https://doi.org/10.1007/s12032-009-9379-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20012234"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20012234"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Matteo Landriscina, Gabriella Laudiero, Francesca Maddalena, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-1256"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-1256"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20647321"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20647321"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Qingchun He, Guiying Zhang, Defu Hou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2011)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21109982"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21109982"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Francesca Maddalena, Gabriella Laudiero, Annamaria Piscazzi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-11-2172"}], "href": "https://doi.org/10.1158/0008-5472.CAN-11-2172"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22052463"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22052463"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yunhui Hu, Xin Cheng, Shuangjing Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Chemother Pharmacol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00280-013-2254-2"}], "href": "https://doi.org/10.1007/s00280-013-2254-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24013575"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24013575"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yunhui Hu, Shuangjing Li, Ming Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-013-2809-2"}], "href": "https://doi.org/10.1007/s10549-013-2809-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24337682"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24337682"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Xuebing Liu, Lei Chen, Bin Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anat Rec (Hoboken) (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ar.22832"}], "href": "https://doi.org/10.1002/ar.22832"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24376145"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24376145"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Gianni Colotti, Elena Poser, Annarita Fiorillo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin, a calcium binding protein involved in the multidrug resistance mechanisms in cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Molecules (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/molecules190913976"}], "href": "https://doi.org/10.3390/molecules190913976"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25197934"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25197934"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Weihua Tong, Donghui Sun, Quan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin Enhances Metastasis and Promotes Epithelial-to-Mesenchymal Transition of Colorectal Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biochem Biophys (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12013-014-0486-3"}], "href": "https://doi.org/10.1007/s12013-014-0486-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25567655"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25567655"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ping Xu, Yong-Fang Jiang, Jing-Hua Wang "}, {"type": "b", "children": [{"type": "t", "text": "shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26045737"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26045737"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ilaria Genovese, Annarita Fiorillo, Andrea Ilari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2017.342"}], "href": "https://doi.org/10.1038/cddis.2017.342"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28726784"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28726784"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Xiu-Qing Lin, Wei Wu, Xin Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "mir-1 inhibits migration of gastric cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Biosci (Landmark Ed) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2741/4813"}], "href": "https://doi.org/10.2741/4813"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31585896"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31585896"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jinguo Zhang, Wencai Guan, Xiaolin Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-021-01891-6"}], "href": "https://doi.org/10.1038/s41388-021-01891-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34163033"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34163033"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Huan Zhang, Shanshan Hu, Jaceline Gislaine Pires Sanches, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin promotes proliferation of hepatocellular carcinoma by regulating VEGFA/B via PI3K pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol Biochem (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13105-024-01011-4"}], "href": "https://doi.org/10.1007/s13105-024-01011-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38536659"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38536659"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Marian B Meyers, Avi Fischer, Yan-Jie Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin regulates excitation-contraction coupling in the heart."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M302009200"}], "href": "https://doi.org/10.1074/jbc.M302009200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12754254"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12754254"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Christian Hansen, Svetlana Tarabykina, Jonas M la Cour, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The PEF family proteins sorcin and grancalcin interact in vivo and in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0014-5793(03)00518-0"}], "href": "https://doi.org/10.1016/s0014-5793(03"}, {"type": "t", "text": "00518-0) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12804766"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12804766"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "K F Frank, B Bölck, Z Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of sorcin enhances cardiac contractility in vivo and in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Cell Cardiol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yjmcc.2005.01.011"}], "href": "https://doi.org/10.1016/j.yjmcc.2005.01.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15808837"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15808837"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Takashi Yokota, Jun Kouno, Koji Adachi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00401-005-1085-6"}], "href": "https://doi.org/10.1007/s00401-005-1085-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16320026"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16320026"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Angélica Rueda, Ming Song, Ligia Toro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin modulation of Ca2+ sparks in rat vascular smooth muscle cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1113/jphysiol.2006.113951"}], "href": "https://doi.org/10.1113/jphysiol.2006.113951"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16931553"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16931553"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Lucyna Mrówczyńska, Ulrich Salzer, Sárka Perutková, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Echinophilic proteins stomatin, sorcin, and synexin locate outside gangliosideM1 (GM1) patches in the erythrocyte membrane."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2010.09.065"}], "href": "https://doi.org/10.1016/j.bbrc.2010.09.065"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20858460"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20858460"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Nafeesa A Noordeen, Gargi Meur, Guy A Rutter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glucose-induced nuclear shuttling of ChREBP is mediated by sorcin and Ca(2+) ions in pancreatic β-cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db10-1329"}], "href": "https://doi.org/10.2337/db10-1329"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22338092"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22338092"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Giao V Q Tran, Trang T D Luong, Eun-Mee Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nonstructural 5A Protein of Hepatitis C Virus Regulates Soluble Resistance-Related Calcium-Binding Protein Activity for Viral Propagation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.02493-15"}], "href": "https://doi.org/10.1128/JVI.02493-15"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26719254"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26719254"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Xiao Yu, Jun Mao, Salma Mahmoud, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Soluble resistance-related calcium-binding protein in cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Chim Acta (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cca.2018.08.034"}], "href": "https://doi.org/10.1016/j.cca.2018.08.034"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30144438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30144438"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Ilaria Genovese, Flavia Giamogante, Lucia Barazzuol, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin is an early marker of neurodegeneration, Ca"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "2+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-03063-y"}], "href": "https://doi.org/10.1038/s41419-020-03063-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33060591"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33060591"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Megumi Kawakami, Tsutomu Nakamura, Noboru Okamura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Pharm Bull (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1248/bpb.30.1065"}], "href": "https://doi.org/10.1248/bpb.30.1065"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17541155"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17541155"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Stefano Franceschini, Andrea Ilari, Daniela Verzili, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular basis for the impaired function of the natural F112L sorcin mutant: X-ray crystal structure, calcium affinity, and interaction with annexin VII and the ryanodine receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.07-8988com"}], "href": "https://doi.org/10.1096/fj.07-8988com"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17699613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17699613"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Jing Li, Bao-An Chen, Min-Sheng Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Influence of tetrandrine on SORCIN gene expression in K562/A02 cell line]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhongguo Shi Yan Xue Ye Xue Za Zhi (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18315902"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18315902"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Vasiliki S Lalioti, Andrea Ilari, David J O'Connell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin links calcium signaling to vesicle trafficking, regulates Polo-like kinase 1 and is necessary for mitosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0085438"}], "href": "https://doi.org/10.1371/journal.pone.0085438"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24427308"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24427308"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Nobuyuki Yamagishi, Ryota Nakao, Rumi Kondo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2014.04.125"}], "href": "https://doi.org/10.1016/j.bbrc.2014.04.125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24796664"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24796664"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Elçin Sehitoğlu, Filiz Cavuş, Canan Ulusoy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Inflamm Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00011-014-0754-0"}], "href": "https://doi.org/10.1007/s00011-014-0754-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25001342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25001342"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Ilaria Genovese, Andrea Carotti, Andrea Ilari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Profiling calcium-dependent interactions between Sorcin and intrinsically disordered regions of human proteome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Gen Subj (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagen.2020.129618"}], "href": "https://doi.org/10.1016/j.bbagen.2020.129618"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32305337"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32305337"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Maria Berrocal, Lucia Saez, Ana M Mata "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer's Disease on the Pump Activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms22116055"}], "href": "https://doi.org/10.3390/ijms22116055"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34205207"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34205207"}]}]}]}
|
| Synonyms | CP22, SCN, CP-22, V19 |
| Proteins | SORCN_HUMAN |
| NCBI Gene ID | 6717 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SRI has 7,979 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 127 datasets.
Click the + buttons to view associations for SRI from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by SRI gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SRI gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SRI gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SRI gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SRI gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SRI gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SRI gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SRI gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SRI gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SRI gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SRI gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SRI gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SRI gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with SRI protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SRI gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SRI gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SRI gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SRI gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SRI gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SRI protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SRI protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SRI protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SRI protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing SRI protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SRI gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SRI gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SRI gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SRI gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with SRI gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of SRI protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SRI gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SRI gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SRI gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SRI gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SRI gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SRI gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SRI gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SRI gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SRI gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SRI from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with SRI gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SRI gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SRI gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SRI gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SRI from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SRI gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SRI gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SRI gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SRI gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SRI gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SRI gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SRI gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SRI gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SRI gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SRI protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing SRI protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SRI protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SRI gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SRI gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SRI gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SRI gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SRI gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SRI gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SRI gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SRI gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SRI gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SRI gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SRI protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SRI gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SRI gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SRI gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SRI from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SRI gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SRI protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SRI gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SRI gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SRI gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate SRI protein from the curated KEA Substrates of Kinases dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate SRI protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SRI gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of SRI gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SRI gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SRI gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SRI gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SRI gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SRI gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing SRI protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SRI protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SRI gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SRI gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SRI gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SRI gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for SRI from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SRI gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SRI gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing SRI protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SRI from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SRI gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SRI gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SRI protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SRI protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with SRI protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate SRI protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of SRI protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Reactome Pathways 2014 | pathways involving SRI protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SRI protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SRI gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SRI gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SRI gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SRI gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SRI gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SRI gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SRI gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with SRI protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SRI gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SRI gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SRI gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SRI gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SRI gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SRI protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SRI protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SRI protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SRI protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SRI protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SRI protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| Virus MINT Protein-Viral Protein Interactions | interacting viral proteins for SRI from the Virus MINT Protein-Viral Protein Interactions dataset. | |
| Virus MINT Protein-Virus Interactions | viruses interacting with SRI from the Virus MINT Protein-Virus Interactions dataset. | |